Maynard Um
-
-
-
-
-
-
-
Phio Pharmaceuticals Announces "Nobel Prize Winning Science Takes on Skin Cancer" in a Fireside Chat with Force Family Office on Wednesday, April 15, 2026
-
-
-
-
-
-
-
Phio Pharmaceuticals to Present at the Life Sciences Investor Forum on March 12, 2026, 11 AM EDT
-
-
-
-
-
-
-
DealFlow Discovery Conference Announces Initial Lineup of Presenting Companies Ahead of Next Week's Event
-
-
-
-
-
-
-
Phio Pharmaceuticals receives FDA acceptance for PH-762 toxicology study
-
-
-
-
-
-
-
Phio Pharmaceuticals Reports Third Quarter 2025 Financial Results and Provides Business Update
-
-
-
-
-
-
-
Phio Pharmaceuticals Announces Positive Pathology Results: Final Maximum Dose Cohort for INTASYL PH-762 Skin Cancer Trial
-
-
-
-
-
-
-
Phio Pharmaceuticals Corp. (PHIO) Files for 1.93M Share Offering by Selling Stockholders
-
400,246 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

